Authors/Disclosures
|
Glen R. Finney, MD, FAAN
(Geisinger Health)
|
Dr. Finney has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Premier Inc. Dr. Finney has a non-compensated relationship as a Board Member with Greater Pennsylvania Chapter of the Alzheimer's Association that is relevant to AAN interests or activities. |
|
Sarah Song, MD, MPH, FAAN
(Rush University Medical Center)
|
Dr. Song has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. |
|
|
No disclosure on file |
|
Valeria Drago, MD
|
No disclosure on file |
|
|
No disclosure on file |
|
Yong Jeong, MD, PhD
|
No disclosure on file |
|
|
No disclosure on file |
|
Tomoyuki Mizuno, MD
|
No disclosure on file |
|
Gregory Crucian
(Univ of Florida)
|
No disclosure on file |
|
Eileen Leary, PhD
(Axsome Therapeutics)
|
Dr. Leary has received personal compensation for serving as an employee of Centessa Pharmaceuticals. Dr. Leary has received personal compensation for serving as an employee of Axsome Therapeutics. Dr. Leary has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Partners Group. Dr. Leary has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulse Infoframe. Dr. Leary has or had stock in Jazz Pharmaceuticals.Dr. Leary has or had stock in Axsome Therapeutics.Dr. Leary has or had stock in Centessa Pharmaceuticals. |
|
Kenneth M. Heilman, MD, FAAN
(Univ. of Florida, Dept. of Neurology)
|
Dr. Heilman has received publishing royalties from a publication relating to health care. |